Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for November 22, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Amaro & Associates New Member to BioOrlando, a council of the Metro Orlando Economic Development Commission (EDC) and Central Florida Chapter of BioFlorida
Amaro & Associates, based in the Central Florida Research Park, has joined BioOrlando, a council of the EDC and Central Florida Chapter of BioFlorida. 
x-small text small text medium text large text


    ORLANDO, FL, November 22, 2008 /24-7PressRelease/ -- Amaro & Associates, based in the Central Florida Research Park, has joined BioOrlando, a council of the EDC and Central Florida Chapter of BioFlorida.

Jorge Amaro, chief executive officer of the firm and a veteran bio-pharmaceutical technology engineer with more than 25 years of experience in the life-sciences industry, said his company is a natural fit within the BioOrlando strategic initiative.

"Our insight into biotechnology company processes, current and relevant industry product and service offerings and strategic proximity to the University of Central Florida's Medical College, Burnham's Research Facility at Lake Nona and the Metro Orlando Economic Development Commission, uniquely positions Amaro & Associates to inject global experience into an already stellar team," said Amaro.

John Fremstad, Vice President, Technology Industry Development, Metro Orlando EDC and BioOrlando's council executive said "BioOrlando has enthusiastically welcomed Amaro and Associates and is excited about the wealth of applicable industry experience Amaro and his staff bring to the table."

BioOrlando's vision is "to build Central Florida's prominence as a preferred destination for healthcare, life science, biotechnology and pharmaceutical companies, as well as their supporting industries" (www.bioorlando.com, 2008).

Amaro and Associates is a client of the University of Central Florida Technology Incubator, part of the UCF Incubation Program.

For more information contact:
Jorge Amaro, Chief Executive Officer, Amaro & Associates 800-835-0495 jamaro@complyshield.com
John Fremstad, Vice President, Technology Industry Development, Metro Orlando EDC 407-422-7159 john.fremstad@orlandoedc.com
Tom O'Neal or Carol Ann Dykes, UCF Incubation Program, 407-882-0202
Larry Vershel or Beth Payan, Larry Vershel Communications, 407-644-4142

About the UCF Incubation Program:
Since its founding in 1999, the UCF Incubation Program has helped more than 100 emerging companies create over $300 million in annual revenue and more than 900 new jobs with an average salary of $59,000. With five facilities across the metro Orlando community, the Incubation Program is a collaboration in economic development between UCF, Orange County, the City of Orlando, Seminole County, the City of Winter Springs, and the Florida High Tech Corridor Council. For more information, please visit http://www.incubator.ucf.edu.

# # #


Read more Press Releases from Larry Vershel:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Larry Vershel
Larry Vershel Communications

Founder/President
629 Executive Drive
Winter Park, FL
USA 32789
Voice: 407-644-4142
Fax: 407-644-4410
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.